This is a routine Form 3 filing with no trading signal. Monitor for future Form 4 filings from Ms. Vousden for any open-market purchases or sales that could provide insider sentiment. The 42,631 share position is small relative to the company's $1.0B market cap and does not indicate material alignment or concern.
Price Chart
Executive Summary
Karen H. Vousden filed an initial statement of beneficial ownership (Form 3) with the SEC, reporting 42,631 shares of Faeth Therapeutics common stock held directly. This is a routine filing required upon becoming a reporting person (officer, director, or >10% holder) and does not reflect a new purchase or sale, nor does it provide any material financial or operational information about the company.
Key Facts
- Karen H. Vousden filed a Form 3 initial statement of beneficial ownership on September 15, 2026, for the period ending September 11, 2026.
- The filing reports 42,631 shares of Faeth Therapeutics common stock held directly by Ms. Vousden.
- A Power of Attorney (Exhibit 24) was included, authorizing Christopher Gerry and Josiah Craver to execute future Forms 3, 4, and 5 on her behalf.
- This filing is a routine administrative requirement for new reporting persons under Section 16(a) of the Exchange Act.
Financial Impact
No financial impact — the filing reports an existing beneficial ownership position, not a transaction.
Risk Factors
- No material risks identified from this filing; it is purely administrative.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001723884-26-000004 |
| Document: 0001723884-26-000004-index-headers.html | 0001723884-26-000004 |
| Document: 0001723884-26-000004-index.html | 0001723884-26-000004 |
| Document: 0001723884-26-000004.txt | 0001723884-26-000004 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 3 | $34.24 $31.55 | ▼ −7.86% | ▼ −10.42% | $28.35 (−17.20%) |
Aug 11, 2026 7w ago | 144 | $28.57 $33.00 | ▼ −15.51% | ▼ −15.91% | $28.35 (+0.77%) |
Aug 4, 2026 8w ago | 8-K | $25.50 $30.00 | ▲ +17.65% | ▲ +17.75% | $28.35 (+11.18%) |
Jul 28, 2026 9w ago | 3 | $28.93 $24.59 | ▼ −15.00% | ▼ −20.53% | $28.35 (−2.00%) |
Jul 2, 2026 13w ago | Insider Cluster | $22.92 $32.54 | ▲ +41.97% | ▲ +41.04% | $28.35 (+23.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access